Registration Dossier

Administrative data

Description of key information

Key value for chemical safety assessment

Skin sensitisation

Endpoint conclusion
Endpoint conclusion:
adverse effect observed (sensitising)
Additional information:

MHHPA is classified as a Category 1 skin sensitiser and CLP (1272/2008/EEC) cites the need for hazard statement H317 (may cause an allergic skin reaction)


Migrated from Short description of key information:
MHHPA is classified as a Category 1 skin sensitiser and CLP (1272/2008/EEC) cites the need for hazard statement H317 (may cause an allergic skin reaction)

Respiratory sensitisation

Endpoint conclusion
Endpoint conclusion:
adverse effect observed (sensitising)
Additional information:

MHHPA is classified as a Category 1 respiratory sensitiser and CLP (1272/2008/EEC) cites the need for hazard statement H334 (may cause allergy or asthma symptoms or breathing difficulties if inhaled)


Migrated from Short description of key information:
MHHPA is classified as a Category 1 respiratory sensitiser and CLP (1272/2008/EEC) cites the need for hazard statement H334 (may cause allergy or asthma symptoms or breathing difficulties if inhaled)

Justification for classification or non-classification

There is no available information on animals.

MHHPA is classified as skin sensitising cat.1 and respiratory sensitising cat.1 according to Regulation 1272/2008/EC and Xn, R42/43 (May cause sensitisation by inhalation and skin contact) according to 67/548/EEC.